Healthcare entity

BeiGene

Company BGNE

All 1 tracked stories fall under one category: market-trends. AACR is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.

Last mentioned: Mar 19, 2026

Entity pulse

Recent coverage · BeiGene

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about BeiGene

All 1 tracked stories fall under one category: market-trends. AACR is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. The 6 average consequence score is above the beat benchmark of 5.8 in the same window. BeiGene appears in 1 tracked Healthcare story from March 18, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering BeiGene. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. AACR Presentation Announcement

    Zymeworks confirms multiple data sessions for Ziihera at the upcoming annual meeting.

  2. Regulatory Progress

    Advancement of Biologics License Application (BLA) filings for lead indications.

  3. ASCO Data Release

    Positive pivotal Phase 2 results in biliary tract cancer (BTC) showcased at ASCO.

Stories mentioning BeiGene 1

BeiGene is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.